| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
St. Petersburg State Pavlov Medical University |
| Information provided by: | St. Petersburg State Pavlov Medical University |
| ClinicalTrials.gov Identifier: | NCT00241995 |
Purpose
The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome
| Condition | Intervention |
|
Topiramate Lamotrigine Memnatine Diazepam Placebo |
Drug: Anticonvulsants |
| ChemIDplus related topics: | Ethanol |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Eligibility
| Ages Eligible for Study: | 20 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Alcohol dependence Alcohol withdrawal syndrome
Exclusion Criteria:
Drug dependence Major psychiatric diagnoses Severe somatic illness
Contacts and Locations More Information
| Study ID Numbers: | RCT-RCT_LOND_GAT_AWS_2003 |
| First Received: | October 17, 2005 |
| Last Updated: | October 17, 2006 |
| ClinicalTrials.gov Identifier: | NCT00241995 |
| Health Authority: | Russia: Ministry of Health and Social Development of the Russian Federation |
|
|
